International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program
August 21, 2018 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Aug. 21, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...